Gut Bacteria Differences Found in IBS Patients With Bacterial Overgrowth

TL;DR

IBS patients with SIBO showed modest differences in fecal microbiota, particularly lower Firmicutes abundance, which was associated with abdominal symptoms and visceral sensitivity.

Key Finding

IBS patients with SIBO had significantly lower levels of Firmicutes (a major group of gut bacteria) compared to healthy controls, and lower Firmicutes levels correlated with more severe abdominal pain and IBS symptoms.

Summary

This study examined differences in gut bacteria between people with irritable bowel syndrome (IBS) who also had small intestinal bacterial overgrowth (SIBO) versus those who did not. SIBO was detected using a hydrogen breath test, which measures hydrogen gas produced by bacteria in the gut. Researchers found that IBS patients with SIBO had lower levels of a bacterial group called Firmicutes, and that lower Firmicutes levels were linked to worse abdominal pain and IBS symptoms. The study included 52 participants total.

Practical Takeaway

This study does not directly test hydrogen water as a treatment. However, it used a hydrogen breath test as a diagnostic tool and highlights how gut bacteria imbalances relate to IBS symptoms. For someone interested in hydrogen research, this study is relevant background science — it suggests that gut bacterial activity and hydrogen gas production are measurable markers of digestive health, though no conclusions about hydrogen water can be drawn from this research.

Abstract (excerpt)

Small intestinal bacterial overgrowth (SIBO) is common in irritable bowel syndrome (IBS) and has been proposed as an etiologic factor. This study aimed to identify potential fecal microbiota profiles in patients with IBS and SIBO. A total of 52 subjects were enrolled in this study, of whom 18 were…

Read the full abstract via DOI